Fan Yu
Ally Bridge Group (ny) Llc
Assets Managed
$123.814M
Holdings
26
Last Quarter
2026 - Q1
Filed Date
3d ago
Growth Rate
28.99%(2Q avg: -6.28%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Ally Bridge Group (ny) Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 26 positions.
Assets under management
The assets under management (AUM) of Ally Bridge Group (ny) Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 123.814M in assets, with a quarterly growth rate of 28.99% and a 2-quarter average growth rate of -6.28%. The portfolio is managed by Fan Yu, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
SLNO Soleno Therapeutics Inc
| 10.82% | $13.392M 400,000 shares@ $33.48 avg price | Increased 138.06% |
PRAX Praxis Precision Medicines I
| 8.54% | $10.571M 32,810 shares@ $322.2 avg price | Increased 65.03% |
NERV Minerva Neurosciences Inc
| 8.06% | $9.974M 1.656M shares@ $6.03 avg price | |
OVID Ovid Therapeutics Inc
| 5.06% | $6.257M 2.818M shares@ $2.23 avg price | Increased 57.9% |
CMPS Compass Pathways Plc
| 4.67% | $5.779M 1.045M shares@ $5.53 avg price | Decreased -5% |
TARS Tarsus Pharmaceuticals Inc
| 4.59% | $5.672M 80,859 shares@ $70.16 avg price | New Position |
SLDB Solid Biosciences Inc
| 4.47% | $5.522M 766,974 shares@ $7.21 avg price | Increased 85.43% |
CMPX Compass Therapeutics Inc
| 4.28% | $5.29M↑ Call 1M shares@ $5.29 avg price | New Position |
PMN Promis Neurosciences Inc
| 4.25% | $5.261M 414,219 shares@ $12.7 avg price | Increased 66.13% |
EWTX Edgewise Therapeutics Inc
| 4.1% | $5.071M 161,000 shares@ $31.5 avg price | Decreased -63.82% |
1-10 of 26